A I Morris

1.9k total citations
54 papers, 1.4k citations indexed

About

A I Morris is a scholar working on Surgery, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A I Morris has authored 54 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 15 papers in Epidemiology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A I Morris's work include Liver Disease Diagnosis and Treatment (9 papers), Esophageal Cancer Research and Treatment (7 papers) and Gastric Cancer Management and Outcomes (6 papers). A I Morris is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Esophageal Cancer Research and Treatment (7 papers) and Gastric Cancer Management and Outcomes (6 papers). A I Morris collaborates with scholars based in United Kingdom, Australia and United States. A I Morris's co-authors include Keith Leiper, L A Turnberg, Ian Gilmore, Jonathan M. Rhodes, R.C. Evans, N Krasner, Anthony Ellis, Robert Sutton, Vanessa Wong and Kevin Dolan and has published in prestigious journals such as Gastroenterology, Cancer and Gut.

In The Last Decade

A I Morris

54 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A I Morris United Kingdom 21 708 397 310 301 251 54 1.4k
Marshall Z. Schwartz United States 30 1.4k 1.9× 526 1.3× 291 0.9× 118 0.4× 220 0.9× 107 2.3k
G Gozzetti Italy 24 931 1.3× 272 0.7× 489 1.6× 392 1.3× 140 0.6× 98 1.9k
Richard J. Hendrickson United States 22 700 1.0× 255 0.6× 287 0.9× 66 0.2× 130 0.5× 97 1.4k
Adriaan C.I.T.L. Tan Netherlands 19 429 0.6× 228 0.6× 184 0.6× 111 0.4× 141 0.6× 60 1.1k
P. Prouse United Kingdom 15 401 0.6× 339 0.9× 249 0.8× 107 0.4× 92 0.4× 31 1.5k
A Benages Spain 21 1.6k 2.3× 279 0.7× 549 1.8× 669 2.2× 261 1.0× 66 2.5k
Charles F. Barish United States 18 727 1.0× 246 0.6× 225 0.7× 716 2.4× 308 1.2× 37 1.8k
Nicholas Burr United Kingdom 20 594 0.8× 227 0.6× 298 1.0× 457 1.5× 271 1.1× 48 1.4k
Alvin M. Zfass United States 22 1.2k 1.7× 726 1.8× 150 0.5× 450 1.5× 40 0.2× 71 1.8k
Jeremiah Levine United States 20 428 0.6× 86 0.2× 308 1.0× 206 0.7× 332 1.3× 87 1.1k

Countries citing papers authored by A I Morris

Since Specialization
Citations

This map shows the geographic impact of A I Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A I Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A I Morris more than expected).

Fields of papers citing papers by A I Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A I Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A I Morris. The network helps show where A I Morris may publish in the future.

Co-authorship network of co-authors of A I Morris

This figure shows the co-authorship network connecting the top 25 collaborators of A I Morris. A scholar is included among the top collaborators of A I Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A I Morris. A I Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leiper, Keith, Katy Martin, Anthony Ellis, et al.. (2008). Clinical trial: randomized study of clarithromycin versus placebo in active Crohn’s disease. Alimentary Pharmacology & Therapeutics. 27(12). 1233–1239. 41 indexed citations
2.
Leiper, Keith & A I Morris. (2007). Treatment of Radiation Proctitis. Clinical Oncology. 19(9). 724–729. 88 indexed citations
3.
Campbell, Fiona, et al.. (2006). Unique Expression of Human Papilloma Virus Type 5 and Type 16 in Esophageal Squamous Cell Carcinoma?A Case Report. The American Journal of Gastroenterology. 101(10). 2423–2426. 4 indexed citations
4.
Morris, A I & Peter Collins. (2005). Treatment of Oesophagogastric Tumours. Endoscopy. 37(1). 19–25. 1 indexed citations
5.
Agrawal, Anurag K., et al.. (2005). Effect of Systemic Corticosteroid Therapy on Risk for Intra-Abdominal or Pelvic Abscess in Non-operated Crohn’s Disease. Clinical Gastroenterology and Hepatology. 3(12). 1215–1220. 41 indexed citations
6.
Scott, Melanie J., et al.. (2003). Combined surgical and endoscopic clearance of small-bowel polyps in Peutz-Jeghers syndrome. Journal of the Royal Society of Medicine. 96(10). 505–506. 11 indexed citations
7.
Dolan, Kevin, A I Morris, John R. Gosney, John K. Field, & Robert Sutton. (2003). Three different subsite classification systems for carcinomas in the proximity of the GEJ, but is it all one disease?. Journal of Gastroenterology and Hepatology. 19(1). 24–30. 14 indexed citations
8.
Dolan, Kevin, A I Morris, John R. Gosney, John K. Field, & Robert Sutton. (2003). Loss of heterozygosity on chromosome 17p predicts neoplastic progression in Barrett's esophagus. Journal of Gastroenterology and Hepatology. 18(6). 683–689. 20 indexed citations
9.
Morris, A I, et al.. (2000). Enteroscopy. Current Opinion in Gastroenterology. 16(2). 121–125. 5 indexed citations
10.
Walker, Steven J., et al.. (1997). Review article: controversy in the therapy of gastro‐oesophageal reflux disease—long‐term proton pump inhibition or laparoscopic anti‐reflux surgery?. Alimentary Pharmacology & Therapeutics. 11(2). 249–260. 16 indexed citations
11.
Wright, Timothy, Michael R. Gray, A I Morris, et al.. (1996). Cost effectiveness of detecting Barrett's cancer.. Gut. 39(4). 574–579. 125 indexed citations
12.
Stretch, Graham L., Barry J. Campbell, A D Dwarakanath, et al.. (1996). 5‐amino salicylic acid absorption and metabolism in ulcerative colitis patients receiving maintenance sulphasalazine, olsalazine or mesalazine. Alimentary Pharmacology & Therapeutics. 10(6). 941–947. 37 indexed citations
13.
Sturgess, Richard & A I Morris. (1995). Metal stents in the oesophagus.. Gut. 37(5). 593–594. 7 indexed citations
14.
Rahman, Khalid, et al.. (1993). Effects of niacin on biliary lipid output in the rat. Biochemical Pharmacology. 45(1). 43–49. 15 indexed citations
15.
Shields, R, S A Jenkins, J N Baxter, et al.. (1992). A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. Journal of Hepatology. 16(1-2). 128–137. 84 indexed citations
16.
Tobin, M V, et al.. (1989). Orocaecal transit time in health and in thyroid disease.. Gut. 30(1). 26–29. 28 indexed citations
17.
Tobin, M V & A I Morris. (1988). Non-psychogenic primary polydipsia in autoimmune chronic active hepatitis with severe hyperglobulinaemia.. Gut. 29(4). 548–549. 1 indexed citations
18.
Krasner, N, et al.. (1984). Is there a place in the United Kingdom for intensive antacid treatment for chronic peptic ulceration?. BMJ. 289(6449). 869–871. 12 indexed citations
20.
Turnberg, L A, et al.. (1978). Intracellular electrolyte depletion in patients with ileostomies.. Gut. 19(6). 563–568. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026